[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"ptau217\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:ptau217":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":29,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":47},"100645708","development-of-a-home-test-for-measuring-blood-p-tau217-in-alzheimers-disease-using-the-tasso-lancet-device-100645708",false,"NCT07701161","Development of a Home Test for Measuring Blood P-tau217 in Alzheimer's Disease Using the Tasso Lancet Device","Inclusion Criteria:\n\n* AD Amyloid PET\u002FCSF confirmed, healthy control, or amyloid-negative non-AD cognitive impairment Age 40-90 Able to complete Tasso and venipuncture collection Caregiver consent\u002Fassistance available if needed\n\nExclusion Criteria:\n\n* Uncontrolled systemic conditions Recent surgery\u002Fhospitalization (3 months) Other dementia drug trial (2 months) Pregnancy Prior Donanemab or Lecanemab use",true,"ALL","40 Years","90 Years",{"count":20,"type":21},1000,"ESTIMATED","OBSERVATIONAL","This study compares p-tau217 concentrations in blood collected via the Tasso device versus standard venipuncture in subjects with and without Alzheimer's disease, including a subset with confirmed amyloid pathology.",[25,26,27,28],"Alzheimer s Disease","MCI Conversion to Dementia","pTau217","Biomarkers",[30,31,32,33,34],"Alzheimer's disease","Neurogen Biomarking","pTau","MCI","Dementia","RECRUITING","2026-07-08",{"date":38,"type":39},"2026-07-14","ACTUAL",{"date":41,"type":39},"2025-01-13",{"date":43,"type":21},"2026-08-01",{"name":45,"class":46},"Neurogen Biomarking LLC","INDUSTRY",5]